[go: up one dir, main page]

NO890824D0 - 1h-imidazo(4,5-c)-kinolin-5-oxydforbindelser. - Google Patents

1h-imidazo(4,5-c)-kinolin-5-oxydforbindelser.

Info

Publication number
NO890824D0
NO890824D0 NO890824A NO890824A NO890824D0 NO 890824 D0 NO890824 D0 NO 890824D0 NO 890824 A NO890824 A NO 890824A NO 890824 A NO890824 A NO 890824A NO 890824 D0 NO890824 D0 NO 890824D0
Authority
NO
Norway
Prior art keywords
carbon atoms
imidazo
group
quinoline
oxydforbindelser
Prior art date
Application number
NO890824A
Other languages
English (en)
Other versions
NO165147C (no
NO890824L (no
NO165147B (no
Inventor
John Franklin Gerster
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO890824L publication Critical patent/NO890824L/no
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Priority to NO890824A priority Critical patent/NO165147C/no
Publication of NO890824D0 publication Critical patent/NO890824D0/no
Publication of NO165147B publication Critical patent/NO165147B/no
Publication of NO165147C publication Critical patent/NO165147C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Physical Water Treatments (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Quinoline Compounds (AREA)
  • Alarm Systems (AREA)
  • Luminescent Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Lubricants (AREA)
NO890824A 1983-11-18 1989-02-27 1h-imidazo(4,5-c)-kinolin-5-oxydforbindelser. NO165147C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO890824A NO165147C (no) 1983-11-18 1989-02-27 1h-imidazo(4,5-c)-kinolin-5-oxydforbindelser.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US55315783A 1983-11-18 1983-11-18
US55315883A 1983-11-18 1983-11-18
NO844565A NO163819C (no) 1983-11-18 1984-11-15 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo(4,5-c)kinolin og derivater derav.
NO890824A NO165147C (no) 1983-11-18 1989-02-27 1h-imidazo(4,5-c)-kinolin-5-oxydforbindelser.

Publications (4)

Publication Number Publication Date
NO890824L NO890824L (no) 1985-05-20
NO890824D0 true NO890824D0 (no) 1989-02-27
NO165147B NO165147B (no) 1990-09-24
NO165147C NO165147C (no) 1991-01-02

Family

ID=27070262

Family Applications (7)

Application Number Title Priority Date Filing Date
NO844565A NO163819C (no) 1983-11-18 1984-11-15 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo(4,5-c)kinolin og derivater derav.
NO890822A NO165145C (no) 1983-11-18 1989-02-27 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo-(4,5-c)-kinolin-4-aminderivater.
NO890824A NO165147C (no) 1983-11-18 1989-02-27 1h-imidazo(4,5-c)-kinolin-5-oxydforbindelser.
NO890825A NO169437C (no) 1983-11-18 1989-02-27 3-amino-kinoliner.
NO890823A NO165146C (no) 1983-11-18 1989-02-27 1h-imidazo-(4,5-c)-kinolin-4-klorforbindelser.
NO890826A NO168705C (no) 1983-11-18 1989-02-27 3-nitro-kinoliner.
NO1999015C NO1999015I1 (no) 1983-11-18 1999-07-08 Imiquimod

Family Applications Before (2)

Application Number Title Priority Date Filing Date
NO844565A NO163819C (no) 1983-11-18 1984-11-15 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo(4,5-c)kinolin og derivater derav.
NO890822A NO165145C (no) 1983-11-18 1989-02-27 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo-(4,5-c)-kinolin-4-aminderivater.

Family Applications After (4)

Application Number Title Priority Date Filing Date
NO890825A NO169437C (no) 1983-11-18 1989-02-27 3-amino-kinoliner.
NO890823A NO165146C (no) 1983-11-18 1989-02-27 1h-imidazo-(4,5-c)-kinolin-4-klorforbindelser.
NO890826A NO168705C (no) 1983-11-18 1989-02-27 3-nitro-kinoliner.
NO1999015C NO1999015I1 (no) 1983-11-18 1999-07-08 Imiquimod

Country Status (15)

Country Link
EP (2) EP0145340B1 (no)
JP (1) JPS60123488A (no)
KR (1) KR900005657B1 (no)
AT (2) ATE49763T1 (no)
AU (2) AU581190B2 (no)
CA (1) CA1271477A (no)
DE (3) DE19975027I2 (no)
DK (6) DK164280C (no)
ES (1) ES8603477A1 (no)
IE (1) IE57874B1 (no)
IL (2) IL84537A (no)
NL (2) NL980041I2 (no)
NO (7) NO163819C (no)
NZ (1) NZ210228A (no)
PH (1) PH22338A (no)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1306260C (en) * 1985-10-18 1992-08-11 Shionogi & Co., Ltd. Condensed imidazopyridine derivatives
US4942168A (en) * 1987-07-13 1990-07-17 Hoechst-Roussel Pharmaceuticals Inc. Hydroxyquinoline amines, and method of enhancing memory in mammals
CA1335996C (en) * 1988-02-16 1995-06-20 Susumu Takada 2-substituted carbonylimidazo¬4,5-c|quinolines
EP0361489A3 (en) * 1988-09-30 1991-06-12 Chugai Seiyaku Kabushiki Kaisha Novel 3,4-diaminoquinoline and pyridine compounds
EP0385630B1 (en) * 1989-02-27 1996-11-27 Riker Laboratories, Inc. 1H-imidazo(4,5-c)Quinolin-4-amines as antivirals
US4994468A (en) * 1989-03-07 1991-02-19 Kyowa Hakko Kogyo Co., Ltd. Imidazoquinolone derivatives
US4929624A (en) * 1989-03-23 1990-05-29 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
CA2021338C (en) * 1989-07-18 1996-07-16 Fumio Suzuki Imidazoquinolone derivatives
US4988815A (en) * 1989-10-26 1991-01-29 Riker Laboratories, Inc. 3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
FR2654021B1 (fr) * 1989-11-07 1992-02-28 Simond Jacques Procede de vitrification de cendres volantes et dispositif pour sa mise en óoeuvre.
GB8928281D0 (en) * 1989-12-14 1990-02-21 Smith Kline French Lab Compounds
EP0459505B1 (en) * 1990-06-01 1996-10-02 Kyowa Hakko Kogyo Co., Ltd. Imidazonaphthyridine derivatives
JP2955019B2 (ja) * 1991-03-01 1999-10-04 ミネソタ マイニング アンド マニュファクチャリング カンパニー １−置換、２−置換１Ｈ−イミダゾ〔４，５−ｃ〕キノリン−４−アミン
US5266575A (en) * 1991-11-06 1993-11-30 Minnesota Mining And Manufacturing Company 2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
IL105325A (en) * 1992-04-16 1996-11-14 Minnesota Mining & Mfg Immunogen/vaccine adjuvant composition
US5395937A (en) * 1993-01-29 1995-03-07 Minnesota Mining And Manufacturing Company Process for preparing quinoline amines
US5693811A (en) * 1996-06-21 1997-12-02 Minnesota Mining And Manufacturing Company Process for preparing tetrahdroimidazoquinolinamines
EP0894797A4 (en) * 1997-01-09 2001-08-16 Terumo Corp NEW AMID DERIVATIVES AND INTERMEDIATES ON YOUR SYNTHESIS
JPH10298181A (ja) * 1997-04-25 1998-11-10 Sumitomo Pharmaceut Co Ltd タイプ２ヘルパーｔ細胞選択的免疫応答抑制剤
JP2000119271A (ja) * 1998-08-12 2000-04-25 Hokuriku Seiyaku Co Ltd １ｈ―イミダゾピリジン誘導体
UA74852C2 (en) * 2000-12-08 2006-02-15 3M Innovative Properties Co Urea-substituted imidazoquinoline ethers
IL161580A0 (en) * 2001-10-23 2004-09-27 Applied Research Systems Pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives and their use
GB0211649D0 (en) * 2002-05-21 2002-07-03 Novartis Ag Organic compounds
WO2004009593A1 (en) 2002-07-23 2004-01-29 Biogal Gyogyszergyar Rt. Preparation of 1h-imidazo[4,5-c]quinolin-4-amines via1h-imidazo [4,5-c]quinolin-4-phthalimide intermediates
AU2003254221A1 (en) 2002-07-26 2004-02-16 Biogal Gyogyszergyar Rt. Preparation of 1h-imidazo (4,5-c) quinolin-4-amines via novel 1h-imidazo (4,5-c) quinolin-4-cyano and 1h-imidazo (4,5-c) quinolin-4-carboxamide intermediates
AU2004266641A1 (en) 2003-08-12 2005-03-03 3M Innovative Properties Company Oxime substituted imidazo-containing compounds
NZ545412A (en) * 2003-08-27 2008-12-24 Coley Pharm Group Inc Aryloxy and arylalkyleneoxy substituted imidazoquinolines
US20050054665A1 (en) 2003-09-05 2005-03-10 3M Innovative Properties Company Treatment for CD5+ B cell lymphoma
CA2536530A1 (en) 2003-10-01 2005-04-14 Taro Pharmaceuticals U.S.A., Inc. Method of preparing 4-amino-1h-imidazo(4,5-c)quinolines and acid addition salts thereof
WO2005032484A2 (en) * 2003-10-03 2005-04-14 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
ITMI20032121A1 (it) * 2003-11-04 2005-05-05 Dinamite Dipharma Spa In Forma Abbr Eviata Dipharm Procedimento per la preparazione di imiquimod e suoi intermedi
JP2007511535A (ja) 2003-11-14 2007-05-10 スリーエム イノベイティブ プロパティズ カンパニー ヒドロキシルアミン置換イミダゾ環化合物
JP2007511527A (ja) 2003-11-14 2007-05-10 スリーエム イノベイティブ プロパティズ カンパニー オキシム置換イミダゾ環化合物
NZ547467A (en) 2003-11-25 2010-06-25 3M Innovative Properties Co Substituted imidazo ring system and methods
WO2005066170A1 (en) 2003-12-29 2005-07-21 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
JP2007517044A (ja) 2003-12-30 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー イミダゾキノリニル、イミダゾピリジニル、およびイミダゾナフチリジニルスルホンアミド
CA2559863A1 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005123080A2 (en) 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006009826A1 (en) 2004-06-18 2006-01-26 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
US7897609B2 (en) 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
WO2006065280A2 (en) 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
JP5313502B2 (ja) 2004-12-30 2013-10-09 スリーエム イノベイティブ プロパティズ カンパニー 置換キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物
US7943609B2 (en) 2004-12-30 2011-05-17 3M Innovative Proprerties Company Chiral fused [1,2]imidazo[4,5-C] ring compounds
AU2006210392A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune response modifiers
AU2006213746A1 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo(4,5-c) ring compounds and methods
CA2602590A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
CA2602683A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
ES2577514T3 (es) 2005-08-22 2016-07-15 The Regents Of The University Of California Antagonistas de TLR
US8846697B2 (en) 2006-05-31 2014-09-30 The Regents Of The University Of California Purine analogs
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
PT2510946E (pt) 2007-02-07 2015-11-23 Univ California Conjugados de agonistas sintéticos de tlr e suas utilizações
EP2009002A1 (en) * 2007-06-21 2008-12-31 Institut National De La Sante Et De La Recherche Medicale (Inserm) New process for the manufacture of 1H-imidazo [4,5-c]-quinoline ring systems
WO2010088924A1 (en) 2009-02-06 2010-08-12 Telormedix Sa Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
EA019768B1 (ru) 2009-02-11 2014-06-30 Дзе Регентс Оф Дзе Юниверсити Оф Калифорния СОЕДИНЕНИЯ, МОДУЛИРУЮЩИЕ АКТИВНОСТЬ Toll-ПОДОБНЫХ РЕЦЕПТОРОВ
PT2606047T (pt) 2010-08-17 2017-04-07 3M Innovative Properties Co Composições, formulações e métodos de um composto lipidado modificador da resposta imunitária
US8728486B2 (en) 2011-05-18 2014-05-20 University Of Kansas Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds
US9873694B2 (en) 2011-10-04 2018-01-23 Janus Biotherapeutics, Inc. Imidazole quinoline-based immune system modulators
CN108250142B (zh) * 2013-02-01 2021-01-26 维尔斯达医疗公司 具有抗炎、抗真菌、抗寄生物和抗癌活性的胺化合物
RU2015144103A (ru) * 2013-03-15 2017-04-28 Зингента Партисипейшнс Аг Микробиоцидно-активные имидазопиридиновые производные
ES2538880B1 (es) * 2013-12-24 2016-09-08 Laboratorios Viñas S.A. Un procedimiento para obtener 4-amino-1-isobutil-1H-imidazo[4,5-c]quinoleína
CA2936376A1 (en) 2014-01-10 2015-07-16 Shanghai Birdie Biotech, Inc. Conjugated compounds and compositions for targeted immunotherapy
JP6760919B2 (ja) 2014-07-09 2020-09-23 バーディー バイオファーマシューティカルズ インコーポレイテッド 腫瘍を治療するための抗ｐｄ−ｌ１組み合わせ
KR102161364B1 (ko) * 2015-09-14 2020-09-29 화이자 인코포레이티드 LRRK2 억제제로서 이미다조[4,5-c]퀴놀린 및 이미다조[4,5-c][1,5]나프티리딘 유도체
CN106943596A (zh) 2016-01-07 2017-07-14 博笛生物科技（北京）有限公司 用于治疗肿瘤的抗-cd20组合
CN106943597A (zh) 2016-01-07 2017-07-14 博笛生物科技（北京）有限公司 用于治疗肿瘤的抗-egfr组合
MX2018012249A (es) 2016-04-19 2019-02-07 Innate Tumor Immunity Inc Moduladores de nlpr3.
US10533007B2 (en) 2016-04-19 2020-01-14 Innate Tumor Immunity, Inc. NLRP3 modulators
US11697851B2 (en) 2016-05-24 2023-07-11 The Regents Of The University Of California Early ovarian cancer detection diagnostic test based on mRNA isoforms
TWI674261B (zh) 2017-02-17 2019-10-11 美商英能腫瘤免疫股份有限公司 Nlrp3 調節劑
CN118515666A (zh) 2017-04-27 2024-08-20 博笛生物科技有限公司 2-氨基-喹啉衍生物
KR20200019226A (ko) 2017-06-23 2020-02-21 버디 바이오파마슈티칼즈, 인크. 약학 조성물
FR3113287B1 (fr) 2020-08-07 2023-06-23 Phv Pharma Procédé industriel de synthèse de l’imiquimod à partir de la quinolèine-2,4-diol applicable à son utilisation pharmaceutique
WO2022125750A1 (en) * 2020-12-09 2022-06-16 Wellstat Therapeutics Corporation Imidazoquinoline compound having anti-inflammatory, antifungal, antiparasitic, and anticancer activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700674A (en) * 1969-04-30 1972-10-24 American Cyanamid Co 4-alkylamino-3-nitroquinolines
IL68495A0 (en) * 1982-05-03 1983-07-31 Lilly Co Eli 2-phenylimidazo(4,5-c)pyridines

Also Published As

Publication number Publication date
NO890822D0 (no) 1989-02-27
NO168705C (no) 1992-03-25
NO169437C (no) 1992-06-24
DE3486043D1 (de) 1993-02-25
NO890825D0 (no) 1989-02-27
AU2991189A (en) 1989-06-15
NZ210228A (en) 1989-01-27
ES537677A0 (es) 1985-12-16
AU581190B2 (en) 1989-02-16
DK164452C (da) 1992-11-09
PH22338A (en) 1988-08-12
DK169179B1 (da) 1994-09-05
DK165921C (da) 1993-06-28
DK136091A (da) 1991-07-16
NO163819B (no) 1990-04-17
EP0145340A2 (en) 1985-06-19
DK135891D0 (da) 1991-07-16
EP0145340A3 (en) 1986-06-11
DK542684D0 (da) 1984-11-15
ES8603477A1 (es) 1985-12-16
DK135991D0 (da) 1991-07-16
DE3481124D1 (de) 1990-03-01
ATE49763T1 (de) 1990-02-15
NO165146C (no) 1991-01-02
DK164451C (da) 1992-11-09
NO890825L (no) 1985-05-20
NO890826L (no) 1985-05-20
DK164455B (da) 1992-06-29
KR850003890A (ko) 1985-06-29
IE842952L (en) 1985-05-18
DK135791D0 (da) 1991-07-16
DE3486043T2 (de) 1993-06-03
JPH0586391B2 (no) 1993-12-10
NO165147C (no) 1991-01-02
NO163819C (no) 1990-08-01
NO890824L (no) 1985-05-20
KR900005657B1 (ko) 1990-08-03
DK135891A (da) 1991-07-16
DK164452B (da) 1992-06-29
NL980043I1 (nl) 1999-02-01
DK164280C (da) 1992-11-30
DK542684A (da) 1985-05-19
NL980041I1 (nl) 1999-02-01
DK136191D0 (da) 1991-07-16
DK135791A (da) 1991-07-16
NO1999015I1 (no) 1999-07-08
CA1271477A (en) 1990-07-10
NL980041I2 (nl) 1999-07-01
EP0310950B1 (en) 1993-01-13
NO890826D0 (no) 1989-02-27
EP0310950A1 (en) 1989-04-12
NO165145C (no) 1991-01-02
NO890823L (no) 1985-05-20
DK136191A (da) 1991-07-16
DK135991A (da) 1991-07-16
DK136091D0 (da) 1991-07-16
NO165147B (no) 1990-09-24
NO169437B (no) 1992-03-16
NO844565L (no) 1985-05-20
ATE84525T1 (de) 1993-01-15
AU611997B2 (en) 1991-06-27
DK164280B (da) 1992-06-01
EP0145340B1 (en) 1990-01-24
NO165146B (no) 1990-09-24
NO168705B (no) 1991-12-16
NO890822L (no) 1985-05-20
DK164455C (da) 1992-11-16
NO165145B (no) 1990-09-24
IL84537A (en) 1990-12-23
DK165921B (da) 1993-02-08
AU3540284A (en) 1985-05-23
DE19975027I2 (de) 2000-09-21
JPS60123488A (ja) 1985-07-02
NO890823D0 (no) 1989-02-27
IE57874B1 (en) 1993-05-05
DK164451B (da) 1992-06-29
IL84537A0 (en) 1988-04-29

Similar Documents

Publication Publication Date Title
DK164452C (da) 3-nitroquinolinderivat

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees